CRIS Current Research Information System

VUKOTIC, RANKA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.932
AS - Asia 2.403
EU - Europa 1.762
AF - Africa 182
Continente sconosciuto - Info sul continente non disponibili 138
SA - Sud America 109
OC - Oceania 2
Totale 7.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.889
VN - Vietnam 742
SG - Singapore 724
CN - Cina 467
GB - Regno Unito 364
IT - Italia 354
SE - Svezia 272
DE - Germania 234
HK - Hong Kong 171
FR - Francia 104
IN - India 98
BR - Brasile 84
IE - Irlanda 77
RU - Federazione Russa 77
NL - Olanda 67
TG - Togo 47
UA - Ucraina 47
CI - Costa d'Avorio 42
ZA - Sudafrica 40
KR - Corea 31
JO - Giordania 29
FI - Finlandia 27
EE - Estonia 25
JP - Giappone 24
PH - Filippine 23
BE - Belgio 22
NG - Nigeria 21
BG - Bulgaria 20
CA - Canada 20
BD - Bangladesh 16
GR - Grecia 16
AR - Argentina 15
TH - Thailandia 13
PL - Polonia 12
CH - Svizzera 11
MX - Messico 11
ID - Indonesia 10
SC - Seychelles 10
TW - Taiwan 9
SA - Arabia Saudita 8
PK - Pakistan 6
TR - Turchia 6
ES - Italia 5
HR - Croazia 5
IQ - Iraq 5
AT - Austria 4
DZ - Algeria 4
EC - Ecuador 4
KE - Kenya 4
RS - Serbia 4
CR - Costa Rica 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
RO - Romania 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GA - Gabon 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
CG - Congo 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
VE - Venezuela 1
ZM - Zambia 1
Totale 7.391
Salva come PNG Salva come JPEG
Città #
Singapore 536
Ashburn 326
Southend 318
Fairfield 279
Chandler 245
Dong Ket 214
Hong Kong 164
San Jose 156
Ho Chi Minh City 145
Woodbridge 134
Seattle 133
Wilmington 124
Houston 118
Santa Clara 117
Hanoi 115
Ann Arbor 114
Cambridge 95
Princeton 78
Dublin 76
Beijing 70
Boardman 63
Bologna 57
Hefei 57
Lomé 47
Abidjan 42
Dallas 39
Lauterbourg 38
Los Angeles 38
New York 36
Westminster 36
Nanjing 35
Amman 29
Haiphong 27
São Paulo 27
Berlin 26
Padova 25
Florence 24
Buffalo 23
Brussels 22
Seoul 22
Abeokuta 21
Council Bluffs 21
Redondo Beach 21
Helsinki 20
Munich 20
Sofia 20
Da Nang 19
Jacksonville 19
Milan 19
Tokyo 19
Bremen 18
Rome 18
Turin 18
Frankfurt am Main 15
Saint Petersburg 15
San Diego 14
Guangzhou 13
Jinan 13
Redmond 11
Bangkok 9
Falkenstein 9
Johannesburg 9
Medford 9
Montreal 9
Nanchang 9
Shenyang 9
Stockholm 9
Bern 8
Des Moines 8
Bengaluru 7
Changsha 7
Chicago 7
Falls Church 7
Hải Dương 7
Shanghai 7
Shijiazhuang 7
Warsaw 7
Wuhan 7
Amsterdam 6
Brooklyn 6
Hangzhou 6
Jiaxing 6
London 6
Nuremberg 6
Thái Nguyên 6
Toronto 6
Turku 6
Yubileyny 6
Zhengzhou 6
Zola Predosa 6
Bühl 5
Chengdu 5
Dearborn 5
Jakarta 5
Lanzhou 5
Lucca 5
Mexico City 5
Ningbo 5
Norwalk 5
Orem 5
Totale 4.877
Salva come PNG Salva come JPEG
Nome #
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 297
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 261
Clinical and serological profile of primary biliary cirrhosis in men. 250
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 244
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 230
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 223
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 222
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 221
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 219
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 218
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 217
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 199
Impact of psychosocial status on liver transplant process 198
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 195
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 193
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 192
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 188
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 184
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 181
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 177
Hepatitis B virus and immune response. 174
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 172
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 157
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 156
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 156
Non-alcoholic steatohepatitis and liver transplantation 155
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 151
LI-RADS: a great opportunity not to be missed 144
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 144
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 138
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 130
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 128
Bone marrow derived stem cells for the treatment of end-stage liver disease. 126
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 125
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 122
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 119
Insights into cancer severity from biomolecular interaction mechanisms 117
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 116
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 111
Familial intrahepatic cholestasis: New and wide perspectives 105
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 103
null 103
null 96
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib 85
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 41
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 25
miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals 20
Totale 7.528
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.392
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022848 88 41 36 50 73 51 21 45 31 73 220 119
2022/20231.015 94 165 60 138 70 82 21 35 186 25 98 41
2023/2024256 19 47 33 21 23 52 10 12 6 18 6 9
2024/2025987 40 109 75 107 153 65 50 32 25 60 38 233
2025/20262.426 238 148 206 179 297 122 263 126 493 192 69 93
2026/202754 54 0 0 0 0 0 0 0 0 0 0 0
Totale 7.528